Before you sell to, join or invest in Click Therapeutics, Inc.
MentionFox check on Click Therapeutics, Inc.: only 1 source on file so far (checked 4 November 2026). Run a full check before you rely on it. mentionfox.com/c/funding/click-therapeutics-inc-form-d-25000001
Check Click Therapeutics, Inc. before you sell to, join or invest Free, no sign-up: every record on file, each linked to its source.
What do you want to do about Click Therapeutics, Inc.?
Based on the record MentionFox holds for this company. No flag is not a clearance.
Click Therapeutics, Inc. filed a Form D with the Securities and Exchange Commission on 2025-04-01.
Click Therapeutics, Inc. filed a Form D notice of an exempt securities offering with the SEC on April 1, 2025. The filing reports $48.58M sold. Its industry group is Other Health Care. It names David Klein (Executive Officer, Director), Randall Stanicky (Executive Officer), Cris De Luca (Director) (SEC Form D, April 1, 2025).
In its own words: “We combine neuroscience with the power of software to create patient-centric digital treatments.” (clicktherapeutics.com, checked October 31, 2026)
Is this your company?
Sell to companies like Click Therapeutics, Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
New Form D on file · 2025-04-01 · the record
Pitching, partnering or investing alongside them? See who really runs and owns Click Therapeutics, Inc.
Free to see. No signup.
More on the people and the money behind Click Therapeutics, Inc., from the filings we hold.
Other Health Care raises by companies based in New York, filed in April 2025, largest first.
Get an email when Click Therapeutics, Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
We'll show it in your MentionFox inbox when Click Therapeutics, Inc. raises, hires or launches. No email unless you switch it on.
Watch Click Therapeutics, Inc. →Get the full cited report on Click Therapeutics, Inc.
What the filing shows about Click Therapeutics, Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News
A Full Report on Click Therapeutics, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
The filing gives Click Therapeutics, Inc.'s address as 80 White Street, New York, NY 10013.
Saved here on this device in the meantime, so nothing is lost either way.
Full funding history for Click Therapeutics, Inc. →
This is the company's own disclosure. A payment disclosed on a Form D is a disclosed use of proceeds, not a finding of wrongdoing.
Order the Full Report on Click Therapeutics, Inc. See pricing
Click Therapeutics, Inc. is a registered filer with the SEC (CIK 1623326) and has filed since 2024-11-21. 4 filings are on record, the latest on 2026-10-01.
A filing shows the company exists and what it reports about itself. It is not an audit or a rating.
Click Therapeutics, Inc.'s Form D of 2025-04-01 names David Klein, Randall Stanicky, Cris De Luca and 8 more as its officers, directors or promoters.
Its new offerings report $109.85M sold across 4 offerings, as its own filings state.
Each marker is one filing. The larger marker is the filing this page is about.
Trailing twelve months. 863 filings in Other Health Care, totalled by week.
Other than the payment of salaries and other compensation and benefits, no officer, director or promoter will receive any payments from the proceeds of this offering.
David Klein is named as Executive Officer and Director on the Form D that Click Therapeutics, Inc. filed with the SEC on 1 April 2025, one of 11 people that filing names.
Randall Stanicky is named as Executive Officer on the Form D that Click Therapeutics, Inc. filed with the SEC on 1 April 2025, one of 11 people that filing names.
Cris De Luca is named as Director on the Form D that Click Therapeutics, Inc. filed with the SEC on 1 April 2025, one of 11 people that filing names.
Lee Shapiro is named as Director on the Form D that Click Therapeutics, Inc. filed with the SEC on 1 April 2025, one of 11 people that filing names.
Jeffrey Berkowitz is named as Director on the Form D that Click Therapeutics, Inc. filed with the SEC on 1 April 2025, one of 11 people that filing names.
Alex Zisson is named as Director on the Form D that Click Therapeutics, Inc. filed with the SEC on 1 April 2025, one of 11 people that filing names.
Maria Forero is named as Director on the Form D that Click Therapeutics, Inc. filed with the SEC on 1 April 2025, one of 11 people that filing names.
Muzammil Mansuri is named as Director on the Form D that Click Therapeutics, Inc. filed with the SEC on 1 April 2025, one of 11 people that filing names.
Lezrene Cunningham is named as Director on the Form D that Click Therapeutics, Inc. filed with the SEC on 1 April 2025, one of 11 people that filing names.
David Friedman is named as Director on the Form D that Click Therapeutics, Inc. filed with the SEC on 1 April 2025, one of 11 people that filing names.
On the filing as: Director.
Anthony Costello is named as Mr. Costello was elected a director upon the effectiveness of the Offering. on the Form D that Click Therapeutics, Inc. filed with the SEC on 1 April 2025, one of 11 people that filing names.
11 people named on the filing — 2 holding an executive role and 9 as directors only.
Named as of the 2025-04-01 filing. Titles and locations are exactly as the filing states — not independently confirmed elsewhere.
No investor is drawn from a Form D — the form states how many invested and never who.
What the filing shows about Click Therapeutics, Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News
A Full Report on Click Therapeutics, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Click Therapeutics, Inc. covers
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
You land back on this company when you are in.
Not ready to upgrade? Keep this one in view instead.
Watchlist Click Therapeutics, Inc.You get an alert in MentionFox the next time this company shows up.
If you're behind Click Therapeutics, Inc.: the weeks after a raise are watched the same way — by other investors sizing you up, and by founders checking who just got funded. FoxPlug turns your commits, deploys, and releases into that story automatically. GetFoxChat puts a guide on your own site so the people this filing just sent you don't leave after one page.
Sourced from the filing index on sec.gov.
Each opens in a new tab, filled in for Click Therapeutics, Inc.. With no account yet, you sign up free and land on the result.
On these lists: Health care raises in New York
Share your raise. This card is drawn from the company's own Form D filing, and sharing needs no account.
https://mentionfox.com/funding/click-therapeutics-inc-form-d-25000001